✦ LIBER ✦

Weekly docetaxel in patients with platinum-refractory metastatic or recurrent squamous cell carcinoma of the head and neck

✍ Scribed by Byoung Chul Cho; Ki Chang Keum; Sang Joon Shin; Hye Jin Choi; Young Joo Lee; Se Hun Kim; Eun Chang Choi; Joo Hang Kim

Publisher: Springer
Year: 2009
Tongue: English
Weight: 239 KB
Volume: 65
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-009-0999-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Weekly docetaxel in patients with recurr

Weekly docetaxel in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck

✍ Ricardo Hitt; Maria L. Amador; Miguel Quintela-Fandino; Antonio Jimeno; Olga del 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB 👁 2 views

Weekly paclitaxel in patients with recur

Weekly paclitaxel in patients with recurrent or metastatic head and neck cancer

✍ M. Tahara; H. Minami; Y. Hasegawa; K. Tomita; A. Watanabe; K. Nibu; M. Fujii; Y. 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 240 KB

Weekly cisplatin paclitaxel and continuo

Weekly cisplatin paclitaxel and continuous infusion fluorouracil in patients with recurrent and/or metastatic head and neck squamous cell carcinoma: a phase II study

✍ M. Schena; C. Barone; N. Birocco; D. Dongiovanni; G. Numico; I. Colantonio; O. B 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 207 KB

Phase II study of paclitaxel, ifosfamide

Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinoma

✍ Dong M. Shin; Fadlo R. Khuri; Bonnie S. Glisson; Lawrence Ginsberg; Vali M. Papa 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

Vinblastine, bleomycin and cisplatin for

Vinblastine, bleomycin and cisplatin for recurrent or metastatic squamous cell carcinoma of the head and neck

✍ David J. Perry; Martin D. Weltz; Archie W. Brown Jr; Robert L. Henderson; Willia 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 315 KB 👁 3 views

Forty-two patients with recurrent or metastatic squamous cell carcinoma of the head and neck were treated with vinblastine, bleomycin, and cisplatin. All patients had received prior surgery, radiation or chemotherapy and all had measurable disease. Forty-five percent of the patients responded with a

Phase II trial of piroxantrone in patien

Phase II trial of piroxantrone in patients with recurrent and metastatic squamous cell carcinoma of the head and neck

✍ Sarah A. Taylor; Jacqueline Benedetti; David Schuller; Stephen P. Richman; Goron 📂 Article 📅 1993 🏛 Springer US 🌐 English ⚖ 161 KB